After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Caredx Inc is listed on the NASDAQ in the Healthcare sector while operating in the Diagnostics & Research industry. The current market capitalization of Caredx Inc is $1.04B. A total of 0.69 million shares were traded on the day, compared to an average of 859.18K shares.
In the most recent transaction, Jain Abhishek sold 265 shares of CDNA for 17.72 per share on Apr 07 ’25. After the transaction, the Chief Financial Officer now owns 337,418 company shares. In a previous transaction on Apr 07 ’25, Novack Jeffrey Adam sold 924 shares at 17.72 per share. CDNA shares that Secretary and General Counsel owns now total 126,911.
Among the insiders who sold shares, Bickerstaff George disposed of 20,000 shares on Mar 10 ’25 at a per-share price of $18.36. This resulted in the Director holding 103,027 shares of CDNA after the transaction. In another insider transaction, GEORGE W BICKERSTAFF bought 20,000 shares at $18.36 per share on Mar 10 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, CDNA has a high of $34.84 and a low of $7.42.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. CDNA’s latest balance sheet shows that the firm has $348.49M in Cash & Short Term Investments as of fiscal 2021. There were $21.35M in debt and $77.30M in liabilities at the time. Its Book Value Per Share was $6.91, while its Total Shareholder’s Equity was $465.88M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CDNA is Buy with a score of 4.25.
